Research by BenfoTeam scientists suggests that in people with early Alzheimer’s disease, thiamine (vitamin B1) does not reach the brain normally, even when blood levels are adequate. Raising blood thiamine well above usual levels may help overcome this. The BenfoTeam trial tests whether benfotiamine, a lab-made form of thiamine, slows cognitive decline in people with mild cognitive impairment or mild dementia due to Alzheimer’s disease.
Enroll Here